The Current Ratio as of December 2025 (TTM) for SynCore Biotechnology Co.,Ltd (4192.TWO) is 11.18

According to SynCore Biotechnology Co.,Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 11.18. This represents a change of -7.69% compared to the average of 12.11 of the last 4 quarters.

SynCore Biotechnology Co.,Ltd (4192.TWO) Historical Current Ratio (quarterly & annually)

How has 4192.TWO Current Ratio performed in the past?

The mean historical Current Ratio of SynCore Biotechnology Co.,Ltd over the last ten years is 6.05. The current 11.18 Current Ratio has changed 18.37% with respect to the historical average. Over the past ten years (40 quarters), 4192.TWO's Current Ratio was at its highest in in the June 2024 quarter at 15.33. The Current Ratio was at its lowest in in the June 2023 quarter at 1.67.

SynCore Biotechnology Co.,Ltd (4192.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of SynCore Biotechnology Co.,Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SynCore Biotechnology Co.,Ltd (4192.TWO) Average Current Ratio

How has 4192.TWO Current Ratio performed in the past?

The current Current Ratio of SynCore Biotechnology Co.,Ltd (4192.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

SynCore Biotechnology Co.,Ltd (4192.TWO) Current Ratio vs. Peers

How is 4192.TWO’s Current Ratio compared to its peers?

SynCore Biotechnology Co.,Ltd’s Current Ratio is less than Andros Pharmaceuticals Co.,Ltd (13.81), less than Eusol Biotech Co.,Ltd. (43.56), less than NatureWise Biotech & Medicals Corporation (11.89), greater than LAUNXP Biomedical Co., Ltd (7.53), greater than TCI GENE Inc. (5.74), greater than PlexBio Co., Ltd. (2.88), greater than Lukas Biomedical Inc. (1.21), less than Bio Preventive Medicine Corp. (19.06), less than AmCad BioMed Corporation (24.52), greater than Level Biotechnology Inc. (1.63),

Build a custom stock screener for SynCore Biotechnology Co.,Ltd (4192.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SynCore Biotechnology Co.,Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SynCore Biotechnology Co.,Ltd (4192.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SynCore Biotechnology Co.,Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.